Dai Okawa
Papers
1
Total Citations
4
H-Index
1
About
Dai Okawa is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes in prostate cancer, particularly through robotic-assisted radical prostatectomy (RARP). His key research areas include the role of lymph node dissection in prostate cancer management, surgical techniques to improve oncologic control, and risk stratification for biochemical recurrence. Okawa's most notable contribution is his 2025 study questioning the therapeutic benefit of extended pelvic lymph node dissection (ePLND) in intermediate- to high-risk prostate cancer patients undergoing RARP. With 4 citations already, this work challenges long-held assumptions about the necessity of aggressive lymph node removal, suggesting it may not improve biochemical recurrence rates. His findings have significant implications for reducing surgical morbidity and refining treatment guidelines. Okawa's research bridges the gap between surgical precision and evidence-based oncology, helping to de-escalate unnecessary procedures without compromising cancer control. His work is particularly valuable for urologists and oncologists seeking to balance therapeutic efficacy with quality of life in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1